Phillip, MosheAchenbach, PeterAddala, AnantaAlbanese-O'Neill, AnastasiaBattelino, TadejBell, Kirstine J.Besser, Rachel E. J.Bonifacio, EzioColhoun, Helen M.Couper, Jennifer J.Craig, Maria E.Danne, Thomasde Beaufort, CarineDovc, KlemenDriscoll, Kimberly A.Dutta, SanjoyEbekozien, OsagieElding Larsson, HelenaFeiten, Daniel J.Frohnert, Brigitte I.Gabbay, Robert A.Gallagher, Mary P.Greenbaum, Carla J.Griffin, Kurt J.Hagopian, WilliamHaller, Michael J.Hendrieckx, ChristelHendriks, EmileHolt, Richard I. G.Hughes, LucilleIsmail, Heba M.Jacobsen, Laura M.Johnson, Suzanne B.Kolb, Leslie E.Kordonouri, OlgaLange, KarinLash, Robert W.Lernmark, ÅkeLibman, IngridLundgren, MarkusMaahs, David M.Marcovecchio, M. LoredanaMathieu, ChantalMiller, Kellee M.O'Donnell, Holly K.Oron, TalPatil, Shivajirao P.Pop-Busui, RodicaRewers, Marian J.Rich, Stephen S.Schatz, Desmond A.Schulman-Rosenbaum, RifkaSimmons, Kimber M.Sims, Emily K.Skyler, Jay S.Smith, Laura B.Speake, CateSteck, Andrea K.Thomas, Nicholas P. B.Tonyushkina, Ksenia N.Veijola, RiittaWentworth, John M.Wherrett, Diane K.Wood, Jamie R.Ziegler, Anette-GabrieleDiMeglio, Linda A.2024-10-302024-10-302024Phillip M, Achenbach P, Addala A, et al. Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes. Diabetologia. 2024;67(9):2012-2014. doi:10.1007/s00125-024-06266-6https://hdl.handle.net/1805/44354en-USAttribution 4.0 InternationalAutoantibodiesGlucose monitoringPreventionType 1 diabetesArticle